Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Safety and Tolerability of Diuretics Withdrawal in Heart Failure With Reduced Ejection Fraction. REDICAE Trial.

NCT05964738 is registered in ClinicalTrials.gov with Maimónides Biomedical Research Institute of Córdoba as lead sponsor.

NCT NCT05964738
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05964738 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Safety and Tolerability of Diuretics Withdrawal in Heart Failure With Reduced Ejection Fraction. REDICAE Trial.
Lead sponsor
Maimónides Biomedical Research Institute of Córdoba
Phase
Phase 2
Overall status
Completed
Start date
December 19, 2022
Completion date
October 31, 2024
Enrollment
98 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

dyspnea, electric impedance, heart failure, safety, withdrawal